Southwest Autism Research & Resource Center
10
4
6
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder
Role: lead
Treatment of Social and Language Deficits With Leucovorin for Young Children With Autism
Role: lead
Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium
Role: lead
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
Role: lead
Telehealth Mindfulness-based Intervention for Adolescents With Autism Spectrum Disorder and Their Caregivers
Role: collaborator
In-Person Mindfulness-based Intervention for Adolescents With Autism Spectrum Disorder and Their Caregivers
Role: lead
Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults
Role: lead
Effect of a Wide Spectrum Nutritional Supplement on Mitochondrial Function in Children With Autism Spectrum Disorder
Role: collaborator
Mindfulness-Based Intervention for Teens With Autism Spectrum Disorder and Their Caregivers
Role: lead
Strengthening Skills Behavioral Intervention for Adults With Autism Spectrum Disorder
Role: lead
All 10 trials loaded